Summary
Two new implantable cardioverter defibrillator systems developed for compatibility with magnetic resonance imaging demonstrate safety and efficacy in the Evera MRI and ProMRI trials, with no significant changes in ventricular pacing threshold < 5.0 V or ventricular sensing. In addition, there were no serious device-related events in both studies.
- implantable cardioverter defibrillators
- ICD
- ventricular pacing
- MRI
- Evera MRI
- ProMRI
- NCT02117414
- NCT02096692
- cardiology & cardiovascular medicine clinical trials
- imaging modalities
- interventional techniques & devices
- © 2015 SAGE Publications
Tools
Table of contents
Cited By...
- No citing articles found.